A little PR push I see, reminiscent of last quarterly (as mentioned in my last post as well). Regardless MEB is grossly undervalued IMO and once we have FDA submission and uptake numbers from subscription product we will get a re-rate and LT holders will be back in the money and some.
- Forums
- ASX - By Stock
- TRI
- Phelps in the news about Medibio
Phelps in the news about Medibio, page-20
-
- There are more pages in this discussion • 8 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TRI (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
0.001(4.76%) |
Mkt cap ! $10.05M |
Open | High | Low | Value | Volume |
2.2¢ | 2.2¢ | 2.2¢ | $340 | 15.45K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 30024 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 192750 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 30024 | 0.022 |
1 | 204176 | 0.021 |
6 | 586260 | 0.020 |
2 | 1000000 | 0.019 |
3 | 1750000 | 0.018 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 192750 | 1 |
0.025 | 136409 | 1 |
0.026 | 655040 | 5 |
0.027 | 500000 | 1 |
0.028 | 160000 | 1 |
Last trade - 10.27am 16/08/2024 (20 minute delay) ? |
Featured News
TRI (ASX) Chart |